BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3321304)

  • 1. Genetic and biochemical analysis of ras p21 structure.
    McCormick F; Levenson C; Cole G; Innis M; Clark R
    Symp Fundam Cancer Res; 1986; 39():137-42. PubMed ID: 3321304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
    Chen SY; Huff SY; Lai CC; Der CJ; Powers S
    Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
    Pai EF; Kabsch W; Krengel U; Holmes KC; John J; Wittinghofer A
    Nature; 1989 Sep; 341(6239):209-14. PubMed ID: 2476675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional homology in GTP-binding proto-oncogene products and elongation factors.
    Halliday KR
    J Cyclic Nucleotide Protein Phosphor Res; 1983-1984; 9(6):435-48. PubMed ID: 6396323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of guanine nucleotide to N-ras p21--a phosphorous and proton magnetic resonance study.
    Grand RJ; Levine BA; Byrd PJ; Gallimore PH
    Oncogene; 1989 Mar; 4(3):355-61. PubMed ID: 2649849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
    Navratil T; Spremulli LL
    Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of intact elongation factor EF-Tu from Escherichia coli in GDP conformation at 2.05 A resolution.
    Song H; Parsons MR; Rowsell S; Leonard G; Phillips SE
    J Mol Biol; 1999 Jan; 285(3):1245-56. PubMed ID: 9918724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
    Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
    J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural differences between a ras oncogene protein and the normal protein.
    Tong LA; de Vos AM; Milburn MV; Jancarik J; Noguchi S; Nishimura S; Miura K; Ohtsuka E; Kim SH
    Nature; 1989 Jan; 337(6202):90-3. PubMed ID: 2642607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasp21 sequences opposite the nucleotide binding pocket are required for GRF-mediated nucleotide release.
    Leonardsen L; DeClue JE; Lybaek H; Lowy DR; Willumsen BM
    Oncogene; 1996 Nov; 13(10):2177-87. PubMed ID: 8950985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural basis of the activation of Ras by Sos.
    Boriack-Sjodin PA; Margarit SM; Bar-Sagi D; Kuriyan J
    Nature; 1998 Jul; 394(6691):337-43. PubMed ID: 9690470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency (139.5 GHz) electron paramagnetic resonance characterization of Mn(II)-H2(17)O interactions in GDP and GTP forms of p21 ras.
    Bellew BF; Halkides CJ; Gerfen GJ; Griffin RG; Singel DJ
    Biochemistry; 1996 Sep; 35(37):12186-93. PubMed ID: 8810926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation.
    Heo J; Prutzman KC; Mocanu V; Campbell SL
    J Mol Biol; 2005 Mar; 346(5):1423-40. PubMed ID: 15713491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.
    Zhang B; Zhang Y; Shacter E; Zheng Y
    Biochemistry; 2005 Feb; 44(7):2566-76. PubMed ID: 15709769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
    Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
    Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
    Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
    Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.